Publications:
Jarvik GP, Hatsukami TS, Carlson CS, Richter RJ, Jampsa R, Brophy VH, Margolin S, Rieder MJ, Nickerson DA, Schellenberg GD, Heagerty PJ, Furlong CE. Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease. Arterioscler Thromb Vasc Biol 23:1465 - 1471, 2003.
Gaynor JW, Gerdes M, Zackai EH, Bernbaum J, Wernovsky G, Clancy RR, Newman MF, Saunders AM, Heagerty PJ, D΄Agostino JA, McDonald-McGinn D, Nicolson SC, Spray TL, Jarvik GP. Apolipoprotein E genotype and neurodevelopmental sequelae of infant cardiac surgery. Journal of Thoracic and Cardiovascular Surgery, 126(6):1736-45, 2003.
Janer M, Fredrickson D, Stanford J, Badzioch M, Kolb S, Deutsch K, Peters MA, Goode EL, Welti R, DeFrance HB, Iwasaki L, Li S, Hood L, Ostrander E, Jarvik GP. A genomic scan of 254 families with hereditary prostate cancer. The Prostate 37:309-19, 2003.
Badzioch M, Igo RP, Gagnon F, Brunzell JD, Krauss RM, Motulsky AG, Wijsman EM, Jarvik GP. LDL particle size loci in familial combined hyperlipidemia: Evidence of multiple loci from a genome scan. Arterioscler Thromb Vasc Biol, 24:1942-50, 2004.
Rozek LS, Hatsukami TS, Richter RJ, Ranchalis J, Nakayama K, Gortner DA, Schellenberg GD, Furlong CE, Jarvik GP. The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease status. J. Lipid Research, 46:1888-95, 2005. |